Absci (ABSI) Operating Leases (2020 - 2026)
Absci's (ABSI) quarterly Operating Leases came in at $2.1 million in Q1 2026, down 46.42% year-on-year from $4.0 million in Q1 2025, and down 18.25% quarter-over-quarter from $2.6 million in Q4 2025.
Absci (ABSI) Operating Leases (2020 - 2026) Analysis & Trends
Absci has disclosed Operating Leases across 7 years of filings, most recently posting $2.1 million for Q1 2026.
- Operating Leases for Q1 2026 came in at $2.1 million, down 46.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (down 46.42% YoY), and the FY2025 annual result was $2.6 million, down 40.75% from the prior year.
- Operating Leases came in at $2.1 million for Q1 2026 at Absci, down from $2.6 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $8.6 million in Q1 2022 to a low of $2.1 million in Q1 2026.
- The 5-year median for Operating Leases is $5.3 million (2024), against an average of $5.4 million.
- Across the five-year window, Operating Leases decreased 8.94% in 2022 and tumbled 46.42% in 2026, its largest moves.
- Absci's Operating Leases stood at $7.3 million in 2022, then declined by 22.88% to $5.6 million in 2023, then decreased by 21.51% to $4.4 million in 2024, then tumbled by 40.75% to $2.6 million in 2025, then fell by 18.25% to $2.1 million in 2026.
- The last three Operating Leases figures came in at $2.1 million (Q1 2026), $2.6 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.15 Mn |
| Dec 31, 2025 | 2.62 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 4.85 Mn |
| Jun 30, 2024 | 5.26 Mn |
| Mar 31, 2024 | 5.30 Mn |
| Dec 31, 2023 | 5.64 Mn |
| Sep 30, 2023 | 6.00 Mn |
| Jun 30, 2023 | 6.42 Mn |
| Mar 31, 2023 | 6.88 Mn |
| Dec 31, 2022 | 7.32 Mn |
| Sep 30, 2022 | 7.85 Mn |
| Jun 30, 2022 | 8.18 Mn |
| Mar 31, 2022 | 8.57 Mn |
| Dec 31, 2021 | 8.97 Mn |
| Sep 30, 2021 | 10.82 Mn |
| Jun 30, 2021 | 8.98 Mn |